Abstract:To elucidate the antileukemi effects of berbamine and the possible molecular mechanisms in vitro and in vivo, MTT method was used to examine the effect of berbamine on K562 cell growth. The apoptosis rate was measured by flow cytometry. The mRNA expression level of BCR/ABL gene (semiquantity value) was determined by RT-PCR and the BCR/ABL protein (P210) level was detected by Western blot. The K562-bearing mice were used to reveal the therapeutic effect in vivo. The results showed that a significant time- and concentration-dependent inhibition of cell growth was found in the cells treated with berbamine. After the cells were exposed to 8.0 microg/ml berbamine for 24, 48 and 72 hours, the percentage of growth inhibition of K562 cells progressively increased by (26.63 +/- 3.57)%, (61.84 +/- 4.74)%, (75.32 +/- 1.95)%, respectively (compared with control, P < 0.01). The IC(50) (72 hours) value was 5.227 +/- 1.307 microg/ml. The apoptosis rate of K562 cells treated with 8.0 microg/ml berbamine for 24 and 72 hours increased from (29.20 +/- 3.82)% to (61.77 +/- 4.35)% (P < 0.01). Berbamine down-regulated the expression levels of bcr/abl gene and P210 in K562 cells in a time- and concentration-dependent manner. The bcr/abl expression decreased from (1.38 +/- 0.02) to (0.97 +/- 0.01) after exposure of the cells to 8.0 microg/ml berbamine for 0 and 72 hours (P < 0.01). When the cells were treated with 4.0 - 16.0 microg/ml berbamine for 24 hours, the level of P210 decreased from (0.95 +/- 0.03) to (0.63 +/- 0.01) (P < 0.01). In vivo, after treatment for 4 weeks, the tumor weight of berbamine-treated group was also lower than that of untreated group [(1.46 +/- 0.43) g vs (2.90 +/- 0.94) g, P < 0.01] and the inhibition rate was 49.66%, moreover, berbamine down-regulated the expression level of bcr/abl gene of tumor cells. It is concluded that berbamine can obviously inhibit the cell proliferation and induce apoptosis in K562 cell lines in a time- and concentration-dependent manner in vitro. The mechanisms of berbamine-induced apoptosis may be involved in down-regulation of bcr/abl gene expression and P210 level. In vivo, berbamine can aslo display a better antileukemic effect and down-regulate expression of bcr/abl gene. Berbamine extracted from Chinese herb may be a promising candidate of new drug for clinical anticancer treatment, especially for bcr-abl(+) diseases.

Inhibition of Glucosamine Sulphate on the Proliferation of Leukemia Cell Line K562

Study on the Apoptosis of K562 Cells Induced by Glucosamine Sulfate

[Effects of Berbamine on K562 Cells and Its Mechanisms in Vitro and in Vivo].

Glucosamine and Glucosamine Hydrochloride Induced Leukemia Cell Line K562 Differentiation into Macrophage

Antitumor Activities of D-glucosamine and Its Derivatives

Preliminary Studies on the Antitumor Activities of D-glucosamine and Its Derivatives

Glucosamine sulfate–induced apoptosis in chronic myelogenous leukemia K562 cells is associated with translocation of cathepsin D and downregulation of Bcl-xL

Anti-proliferative Potential of Glucosamine in Renal Cancer Cells Via Inducing Cell Cycle Arrest at G0/G1 Phase

Antiproliferation and apoptosis of K562 cells by Astragalus Mongholicus Lectin

[Role of Bcl-xL in the cathepsin D-associated apoptosis of K562 cells].

Effect of RSK inhibitor BI-D1870 on proliferation of acute leukemia cells

[Effect of BRD4 Inhibitor GSK525762A on Proliferation and Apoptosis of KU812 Leukemic Cells and Its Mechanism].

Inhibition of Proliferation and Induction of Apoptosis by Simvastatin in K562 Le Ukemic Cell Line

Effect of Curcumin Microemulsion on Proliferation and Apoptosis of Human Leukemia Cell Line K562 Cells

D-Glucosamine-induced increase of the glycerol-containing lipids in growing cultures of human malignant epithelial cells

Inhibitory effect of juglone on proliferation of leukemia cells

Apoptosis of Leukemia K562 Cells Induced by Scutellaria Barbata Extract

Study on the Effects of Tanshinone Derivates on Growth Inhibition and Apoptosis Induction in Human Erythroleukemia Cell Line K562

To Study the Proliferative Inhibition of Anticancer Drug in Two Kinds of Ph (+) Leukemia Cell Lines.

Inhibition on Liver Carcinoma Cells HepG2 by Se-methylselenocysteine

Effects of Curcumin on Solid Tumor and Acute Myeloid Leukemic Cells